"Dyslipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Descriptor ID |
D050171
|
| MeSH Number(s) |
C18.452.584.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dyslipidemias".
Below are MeSH descriptors whose meaning is more specific than "Dyslipidemias".
This graph shows the total number of publications written about "Dyslipidemias" by people in this website by year, and whether "Dyslipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 4 | 5 |
| 2016 | 7 | 0 | 7 |
| 2017 | 48 | 26 | 74 |
| 2018 | 62 | 21 | 83 |
| 2019 | 25 | 8 | 33 |
| 2020 | 4 | 12 | 16 |
| 2021 | 9 | 3 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status]. Nutr Hosp. 2021 Oct 13; 38(5):1068-1074.
-
Dyslipidaemia and mortality in COVID-19 patients: a meta-analysis. QJM. 2021 Oct 07; 114(6):390-397.
-
Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study. J Clin Hypertens (Greenwich). 2021 09; 23(9):1664-1674.
-
The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence. Curr Opin Lipidol. 2021 08 01; 32(4):231-243.
-
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis. Virol J. 2021 07 27; 18(1):157.
-
Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19. Diabetes Care. 2021 09; 44(9):2149-2157.
-
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr Metab Cardiovasc Dis. 2021 08 26; 31(9):2619-2627.
-
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study. BMJ Open Respir Res. 2021 07; 8(1).
-
Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study. J Cardiovasc Pharmacol. 2021 07 01; 78(1):e94-e100.
-
Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front Endocrinol (Lausanne). 2021; 12:611526.